Skip to content

Category Archives: CMS Memo

CMS Memorandum S&C 14-43-NH: Completion of Minimum Dada Set(MDS) 3.0 Discharge Assessments for Transfer from Medicare- and/or Medicaid-Certified Beds to Non-Certified Beds

CMS reinforces the need to do MDS discharge assessments in the attached Survey & Certification memo 14-43-NH dated August 25, 2014.  Specifically, if a resident is moving from a certified bed to a non-certified bed in the same facility, then a discharge assessment is completed and transmitted.  The reverse then would apply:  If the resident moves from a non-certified bed to a certified bed, the OBRA MDS process begins.  The MDS is required to be completed and transmitted only for certified beds.  Furthermore, if a facility chooses to do the MDS for a non-certified bed, then they must not transmit that MDS.

View the memo here:  S&C 14-43-NH or visit http://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Policy-and-Memos-to-States-and-Regions-Items/Survey-and-Cert-Letter-14-43.html

Announcement from CMS – National Provider Call: QIO Program Transition

You are invited to join the Centers for Medicare and Medicaid Services (CMS) – Center for Clinical Standards and Quality, for a discussion on the restructuring of Quality Improvement (QIO) Program effective August 1, 2014.  We recognize the unique impact of the changes on the provider community as it relates to areas such as provider’s procedures for notifying beneficiaries regarding rights to appeals of discharge determinations, addressing quality of care concerns, provision of medical records, working on quality improvement initiatives and receiving technical assistance on value and incentive programs.  The purpose of this meeting is to share an overview of the QIO Program changes, provide an update on the transition process, discuss its impact on the provider community, share critical resources, and to answer any questions.

We have scheduled the National Provider Call for Wednesday, July 23, 2014 from 11:00 am – 12:00 pm EDT (10:00 am – 11:00 am CDT) via webinar.

Here is how you can join:

Audio:  Telephone Number: 1-877-267-1577

MeetingPlace ID: 993 182 797 (This meeting does not require a password.)

Webinar:  https://webinar.cms.hhs.gov/qio-provider-call/

Users without an Adobe Connect login may sign-in as a guest.  Pre-registration is not required.  This session will be recorded.  Thank you for your participation in this call to advance health care quality for Medicare beneficiaries.  We look forward to hearing from you.

CMS Memorandum S&C 14-34-NH: Advance Copy of Revised F371; Preparation of Eggs in Nursing Homes

CMS Memorandum S&C 14-34-NH:  Advance Copy of Revised F371; Interpretive guidance and Procedures for Sanitary Conditions, Preparation of Eggs in Nursing Homes

Summary:

  • Guidance for Nursing Homes: Skilled nursing and nursing facilities should use pasteurized shell eggs or liquid pasteurized eggs to eliminate the risk of residents contracting Salmonella Enteritidis (SE).  The use of pasteurized eggs allows for resident preference for soft-cooked, undercooked or sunny-side up eggs while maintaining food safety.  In accordance with the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) standards, skilled nursing and nursing facilities should not prepare nor serve soft-cooked, undercooked or sunny-side up eggs from unpasteurized eggs.
  • Guidance for Surveyors: Signed health release agreements between the resident (or the resident’s representative) and the facility that acknowledges the resident’s acceptance of the risk of eating undercooked unpasteurized eggs are not permitted.  Pasteurized eggs are commercially available and allow the safe consumption of eggs.  If the facility prepares or serves unpasteurized or undercooked eggs which are not cooked until both the yolk and white are completely firm, surveyors should consider citing deficiencies at F371.  Determination of the appropriate scope and severity shall be based upon the actual or potential negative resident outcomes in accordance with guidance given at F371.  We are revising F371 to clarify this section; a revised F371 is attached.

View the memo here:  S&C 14-34-NH or visit www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Policy-and-Memos-to-States-and-Regions-Items/Survey-and-Cert-Letter-14-34-.html?DLPage=1&DLSort=2&DLSortDir=descending.

CMS Memorandum S&C 14-30-NH: Grant Solicitation for the Reinvestment of Federal Civil Money Penalty (CMP) Funds

CMS Memorandum S&C 14-30-NH:  Grant Solicitation for the Reinvestment of Federal Civil Money Penalty (CMP) Funds to Benefit Nursing Home Residents

Summary:

  • Grant Solicitation for the Reinvestment of Civil Money Penalty (CMP) Funds to Benefit Nursing Home Residents: As part of the 2010 Affordable Care Act, the Centers for Medicare & Medicaid Services (CMS) is soliciting proposals for a grant opportunity in which Federal CMP Funds will be utilized to support and further expand the National Partnership to Improve Dementia Care in Nursing Homes.
  • Funds: A total of $500,000 for FY2014-2015 will be available for a three year period of performance.  Funding will be awarded in 12 month budget periods.
  • Terms: Further information about this new initiative may be accessed at http://www.grants.gov.

View the memo here:  S&C 14-30-NH or visit www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Policy-and-Memos-to-States-and-Regions-Items/Survey-and-Cert-Letter-14-30.html?DLPage=1&DLSort=2&DLSortDir=descending.

CMS Memorandum S&C 14-25-NH: Advance Copy – Single Use Device Reprocessing under Tag F441

CMS Memorandum S&C 14-25-NH:  Advance Copy – Single Use Device Reprocessing under Tag F441, Revisions to Interpretive Guidance in Appendix PP, State Operations Manual (SOM) on Infection Control

Summary:

  • Advance Copy: The guidance under Tag F441, Infection Control, Preventing Spread of Infection/Indirect Transmission has been revised.
  • Single-Use Device Guidance: Nursing homes may purchase reprocessed single-use devices when these devices are reprocessed by an entity or a third party reprocessor that is registered with the Food and Drug Administration.
  • Single-Use Device (SUD): A SUD is a device that is intended for one use on a single patient during a single procedure.
  • Reprocessed SUD: A reprocessed SUD is an original device that has previously been used on a patient and has been subjected to additional processing and manufacturing for the purpose of an additional single use on a patient.

View the memo here:  S&C 14-25-NH or visit www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Policy-and-Memos-to-States-and-Regions-Items/Survey-and-Cert-Letter-14-25.html?DLPage=1&DLSort=2&DLSortDir=descending.